Management Options for Irritable Bowel Syndrome

Area of Science:

• Gastroenterology
• Neurogastroenterology
• Pharmacology

Background:

• Irritable bowel syndrome (IBS) presents with varied symptoms and underlying pathophysiologies.
• Key mechanisms include altered colonic motility, heightened intestinal sensitivity, bile acid dysregulation, and mucosal inflammation.
• Epithelial barrier defects and neurohormonal imbalances also contribute to IBS pathogenesis.

Purpose of the Study:

• To review the diverse pathophysiologic mechanisms of IBS.
• To discuss current and novel therapeutic strategies for IBS management.
• To highlight the need for improved pain relief treatments in IBS.

Main Methods:

• Literature review of IBS pathophysiology and treatment modalities.
• Analysis of mechanisms including motility, sensation, inflammation, and barrier function.
• Evaluation of current and emerging therapeutic approaches.

Main Results:

• IBS is characterized by multifactorial mechanisms affecting gut function and sensation.
• Current treatments target motility, sensation, and the intraluminal environment.
• Lifestyle, diet, probiotics, and pharmacotherapy are key interventions.

Conclusions:

• Understanding IBS pathophysiology is crucial for effective treatment.
• Novel therapies are needed to address pain without central adverse effects.
• Integrated approaches combining lifestyle, diet, and targeted pharmacotherapy show promise.